Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Protein Succinylate in Heart Failure with Iron Deficiency
NCT03344523Phase 4Unknown
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Jan 2018
- Primary completion
- Dec 2019
- Modality
- DNA Intercalators/Alkylators, Recombinant Proteins and Enzymes, Covalent Small Molecules
01
Overview
A Phase 4 trial of Iron protein succinylate in iron deficiency anemia (IDA), sponsored by Lee's Pharmaceutical Holdings Limited. Status: unknown.
02
Drugs
Iron protein succinylate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03344523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03344523.